SAP30 and neoplasm: Next, we studied the effect of SAP30 on circulating tumor cells (CTCs) in the orthotopic xenograft mouse model and found that CTCs were markedly eliminated in blood from mice bearing SAP30-KO1 or -KO2 tumors (Figure 2J).